Biden signs defense spending bill funding psychedelic research
President Joseph Biden… signed a defense spending bill that funds clinical trials researching psychedelic drugs to treat post-traumatic stress disorder and traumatic brain injuries experienced by active-duty members of the U.S. military. The president signed the legislation, known as the National Defense Authorization Act (NDAA)… after the bill was approved by Congress earlier this month [December 2023].
Under the legislation, the Department of Defense would be required to establish a system to allow active-duty service members with post-traumatic stress disorder (PTSD) or traumatic brain injuries (TBI) to participate in clinical trials studying the psychedelic drugs psilocybin, MDMA, ibogaine and 5-MeO-DMT as treatments for their conditions. The legislation appropriates $10 million for psychedelics research, which could be conducted in conjunction with academic institutions and eligible federal and state agencies. The measure also sets a 180-day time limit from the day the bill becomes effective for the Department of Defense to establish the psychedelics research program.
Original Article (Forbes):
Biden signs defense spending bill funding psychedelic research
Artwork Fair Use: Public Domain
